A detailed history of Vaughan Nelson Investment Management, L.P. transactions in Eli Lilly & CO stock. As of the latest transaction made, Vaughan Nelson Investment Management, L.P. holds 264,360 shares of LLY stock, worth $211 Million. This represents 1.91% of its overall portfolio holdings.

Number of Shares
264,360
Holding current value
$211 Million
% of portfolio
1.91%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 22, 2025

BUY
$625.65 - $812.69 $165 Million - $215 Million
264,360 New
264,360 $202 Million
Q4 2023

Jan 24, 2024

BUY
$525.19 - $619.13 $4,201 - $4,953
8 New
8 $5,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $760B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Vaughan Nelson Investment Management, L.P. Portfolio

Follow Vaughan Nelson Investment Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan Nelson Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Vaughan Nelson Investment Management, L.P. with notifications on news.